EXOZYMES INC. Operating Lease, Expense
EXOZYMES INC. (EXOZ) reported Operating Lease, Expense of $20.90 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-05-14
- EXOZYMES INC. operating lease, expense for the quarter ending 2026-03-31 was $20.90K, a 185.71% increase year-over-year.
- EXOZYMES INC. operating lease, expense for the quarter ending 2025-03-31 was $7.31K.
| Period end | Operating Lease, Expense 3 month |
|---|---|
| 2026-03-31 | $20.90K 10-Q · filed 2026-05-14 |
| 2025-03-31 | $7.31K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |